Drug Profile
Estradiol/testosterone topical gel - ANI Pharmaceuticals/Endo
Alternative Names: LibiGel-E/T; Testosterone/estradiol topical gel - ANI Pharmaceuticals/EndoLatest Information Update: 26 May 2022
Price :
$50
*
At a glance
- Originator Antares Pharma
- Developer Endo International
- Class Estradiol congeners; Estrenes; Hormonal replacements; Testosterone congeners
- Mechanism of Action Androgen receptor agonists; Estrogen receptor agonists; Testosterone agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- No development reported Female sexual dysfunction; Hot flashes
Most Recent Events
- 24 May 2022 Antares Pharma has been acquired by Halozyme Therapeutics
- 21 Aug 2015 No recent reports of development identified - Phase-II for Female sexual dysfunction in Canada (Transdermal)
- 21 Aug 2015 No recent reports of development identified - Phase-II for Hot flashes in Canada (Transdermal)